omalizumab   Click here for help

GtoPdb Ligand ID: 6890

Synonyms: IGE25 | olizumab | R03DX05 | RG-3648 | rhumab-E25 | Xolair®
Approved drug Immunopharmacology Ligand
omalizumab is an approved drug (FDA (2003), EMA (2005))
Compound class: Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Peptide sequence analysis reveals that omalizumab is clone e25 in patent US5994511 [3].
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: omalizumab

Immunopharmacology Disease
Disease X-Refs Comment References
Chronic idiopathic urticaria An anti-IgE therapy approved to treat antihistamine-resistant chronic idiopathic urticaria .
Asthma Disease Ontology: DOID:2841
OMIM: 600807
An anti-IgE therapy approved to treat persistent and severe asthma inadequately controlled by inhaled corticosteroids.